NeuroSense Therapeutics’ (NASDAQ:NRSN – Get Rating) lock-up period is set to end on Tuesday, June 7th. NeuroSense Therapeutics had issued 2,000,000 shares in its public offering on December 9th. The total size of the offering was $12,000,000 based on an initial share price of $6.00. After the end of the company’s lock-up period, restrictions preventing […]
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 98,500 shares, a growth of 64.2% from the April 30th total of 60,000 shares. Based on an average daily trading volume, of 4,200,000 shares, […]
ImmunoGen (NASDAQ:IMGN – Get Rating) and NeuroSense Therapeutics (NASDAQ:NRSN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings and […]